Janus Global Life Sciences Fund (JAGLX)

Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 5/27/16)$47.68
Total Net Assets (As of 4/30/16)$3.91B
Annual Expense Ratio
(As of fiscal year end 9/30/15)
GROSS 0.95%
NET 0.95%

Performance (As of 3/31/16)
1 Year-17.28%
3 Year19.68%
5 Year19.69%
10 Year11.29%
Morningstar (As of 4/30/16)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

124 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Returns greater than one year are annualized.

Data as of 4/30/16. Index represents the MSCI World Health Care Index.

TOP HOLDINGS (% of Fund)

Amgen Inc 3.73
AbbVie Inc 3.20
Celgene Corp 3.13
Bristol-Myers Squibb Co 2.96
Allergan plc 2.69
Aetna Inc 2.57
Boston Scientific Corp 2.52
Universal Health Services Inc 2.46
Teva Pharmaceutical Industries Ltd (ADR) 2.46
Pfizer Inc 2.43
TOTAL28.15

CHARACTERISTICS

Number of Holdings
Equity Issues

93
Market Capitalization
Weighted Average
Median

$49.25B
$29.69B
Portfolio Turnover Ratio
(1-year trailing)

48.84%
Price/Earnings Ratio
(1-year forward)

17.85
Price/Book Ratio
(1-year forward)

4.73
Earnings Growth Rate
(1-year forward)

8.87%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
St Jude Medical Inc
Boston Scientific Corp
Bristol-Myers Squibb Co
AbbVie Inc
Pfizer Inc
DETRACTORS
Actavis PLC
Gilead Sciences Inc
FibroGen Inc
Amicus Therapeutics Inc
Horizon Pharma Plc

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 98.44 100.00
 
 
US Industrials 0.32 -
 
Cash & Equivalents 1.20 -
 
Restricted Cash 0.04 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 78.37 65.96
Non-U.S. Developed 20.39 34.04
Restricted Cash 0.04 -
Cash & Equivalents 1.20 -

REGIONS (%)

FUNDINDEX
North America 78.36 66.22
Europe 17.10 25.21
Africa/Mideast 2.46 1.27
Japan 0.84 5.85
Cash & Equivalents 1.20 -
Restricted Cash 0.04 -

COUNTRIES (%)

FUNDINDEX
United States 78.36 65.97
United Kingdom 5.91 5.57
France 4.27 2.94
Switzerland 3.46 9.29
Israel 2.46 1.27
Denmark 2.43 3.05
Germany 0.99 3.79
Japan 0.84 5.85
Netherlands 0.04 -
Cash & Equivalents 1.20 -
Restricted Cash 0.04 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 16.83 46.00
$50 Billion to $100 Billion 19.48 17.58
$10 Billion to $50 Billion 27.31 31.25
$5 Billion to $10 Billion 11.82 4.08
$1 Billion to $5 Billion 13.28 1.09
$500 Million to $1 Billion 6.25 -
$250 Million to $500 Million 1.26 -
$100 Million to $250 Million 0.62 -
N/A 1.59 -

TOP INDUSTRIES (%)

FUNDINDEX
Biotechnology 34.54 17.21
Pharmaceuticals 33.60 51.56
Health Care Equipment 10.31 11.67
Health Care Services 4.99 3.61
Health Care Facilities 4.48 1.34
Managed Health Care 4.40 6.52
Health Care Distributors 2.44 2.56
Health Care Technology 2.22 0.65
Life Sciences Tools & Services 1.11 3.13
Health Care Supplies 0.35 1.75

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.